Almanack Investment Partners’s Lixte Biotechnology LIXT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-24,808
| Closed | -$185K | – | 849 |
|
|
2022
Q2 | $185K | Sell |
24,808
-49,600
| -67% | -$370K | 0.02% | 414 |
|
|
2022
Q1 | $915K | Sell |
74,408
-3,500
| -4% | -$43K | 0.08% | 162 |
|
|
2021
Q4 | $927K | Sell |
77,908
-2,697
| -3% | -$32.1K | 0.08% | 158 |
|
|
2021
Q3 | $1.68M | Sell |
80,605
-17,600
| -18% | -$366K | 0.15% | 104 |
|
|
2021
Q2 | $2.98M | Sell |
98,205
-6,006
| -6% | -$182K | 0.28% | 66 |
|
|
2021
Q1 | $3.43M | Buy |
+104,211
| New | +$3.43M | 0.35% | 61 |
|